Silgan (SLGN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
29 Jul, 2026Executive summary
Delivered solid Q2 2026 results with net sales of $1.64 billion, up 7% year-over-year, overcoming cost inflation, volatile order patterns, and mixed market conditions.
Outperformed end-market trends, especially in Dispensing and Specialty Closures and wet pet food Metal Containers, with high single digit volume growth in these segments.
Successfully executed a new long-term supply agreement in the vegetable market, resolving multi-year disruption.
H1 2026 performance slightly ahead of original expectations.
Net income for Q2 2026 was $75.8 million ($0.72 per diluted share), down from $89.0 million ($0.83 per diluted share) in Q2 2025; adjusted net income per diluted share was $0.98 versus $1.01 last year.
Financial highlights
Net sales reached $1.64 billion, up 7% year-over-year, mainly from higher raw material cost pass-throughs and strong volume growth.
Adjusted EBIT was $185 million, down 4% year-over-year, with Custom Containers up but Metal Containers down; EBIT for Q2 2026 was $151.0 million, a decrease from $167.5 million in Q2 2025.
Adjusted EPS was $0.98, down $0.03 from prior year, due to lower EBIT partially offset by lower interest expense.
Dispensing and Specialty Closures sales up 2% to $713.9 million, Metal Containers sales up 13% to $763.9 million, Custom Containers sales up 3% to $165.5 million.
Gross profit for Q2 2026 was $294.9 million, slightly down from $299.1 million in Q2 2025; gross margin was 17.9%, down from 19.4%.
Outlook and guidance
Confirmed 2026 adjusted EPS guidance of $3.73–$3.93 (vs. $3.72 in 2025), a 3% increase at midpoint.
Q3 2026 adjusted EPS expected at $1.21–$1.31 (vs. $1.22 prior year), with higher EBIT and volumes in all segments.
Free cash flow for 2026 estimated at ~$450 million, including CapEx of ~$310 million.
Volume growth expectations: low to mid-single digit for Dispensing and Specialty Closures, low single digit for Metal Containers and Custom Containers.
Adjusted EBIT in 2026 expected to be higher than 2025 in all segments.
Latest events from Silgan
- Q1 2026 sales up 6.4%, adjusted EPS $0.78, and full-year guidance increased.SLGN
Q1 20266 May 2026 - Proxy covers director elections, incentive plan amendment, auditor ratification, and say-on-pay.SLGN
Proxy filing16 Apr 2026 - Record 2025 growth in key segments, with further earnings and cash flow gains expected in 2026.SLGN
Q4 20254 Feb 2026 - €838M acquisition expands dispensing leadership, targets €20M synergies and 10% EPS accretion.SLGN
M&A Announcement3 Feb 2026 - Q2 net sales fell 3.2% to $1.38B, but gross margin and adjusted EPS both increased.SLGN
Q2 20242 Feb 2026 - Q3 2024 saw record dispensing growth and Weener acquisition, setting up strong 2025 prospects.SLGN
Q3 202417 Jan 2026 - Record Q4 results and 2025 double-digit growth outlook driven by acquisitions and dispensing demand.SLGN
Q4 20249 Jan 2026 - Record Q1 2025 sales and earnings growth driven by Weener acquisition and volume gains.SLGN
Q1 202524 Dec 2025 - Proxy covers director elections, auditor ratification, say-on-pay, and strong governance.SLGN
Proxy Filing1 Dec 2025